Eccrine Spiradenoma
Low-grade malignant eccrine spiradenoma metastasizes systemically
Published in Cancer Weekly, August 19th, 2003
"Malignant eccrine spiradenoma (MES) is a very rare tumor. Tumors can be low grade or high grade. There are nine cases in the literature with systemic metastases," scientists in England report.
"Of these, only one was low grade; the others had obvious features of high-grade malignancy such as pleomorphism, increased mitoses, and abnormal mitoses," wrote N. Leonard and colleagues, Royal Liverpool Hospital, Department of Histopathology.
"Low grade MESs are more difficult to diagnose and are said to have a better prognosis. We report an additional case of low-grade...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-08-19)
More Articles from Cancer Weekly
- Cancer Vaccine
CD80 and CD86 expression produces tumor vaccine better than either alone - Gene Silencing
New mechanism identified - Cancer Risk Factors
Scottish study reveals cancer risk of HIV - Nicotine Addiction
College smokers report feeling "invulnerable" to tobacco's effects - Pancreatic Cancer
IL-13 cytotoxin exhibits potent effect against human pancreatic tumors - Pilocytic Astrocytoma
Protein can predict progression of most common childhood brain tumor - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
